The device addresses the several limitations of existing inhalers through its innovative design and process, facilitating effortless inhalation, efficient lung deposition, as well as convenient handling and portability. This will provide a more effective, secure, and convenient treatment option for the majority of COPD patients. Following Singmed's exclusive upgrade, our self-developed SMI device is equipped with micro-channel silicon-based chips which enable full atomization of the active pharmaceutical ingredients. In comparison to other inhalation devices, this device's internal design allows for spray generation solely through mechanical means without any propellant. Consequently, patients have an extended period to inhale the drug and ensure it reaches their lungs effectively. This enables true substitution to the novel device.